In a recent study, we screened the tumor microenvironment of various tumors for a novel regulatory B cell subset characterized by unique expression of the serine protease granzyme B (GrB) and potent GrBdependent T cell-suppressive activity [2]. The gene discussed is GZMB; the disease is neoplasm.